Home›Articles›How teserpaturev moved from fast-track status to approval in JapanArticleHow teserpaturev moved from fast-track status to approval in JapanArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnTeserpaturev, Drugs and Medicinal Substances Well-attested SourcesTeserpaturev (Wikipedia)Lead paragraphQuote, Lead paragraphTeserpaturev was granted Sakigake fast-track designation in February 2016, orphan drug designation (ODD) in July 2017, and was approved in June 2021 by the Japanese Ministry of Health, Labour and Welfare (MHLW).View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.